Loading clinical trials...
Loading clinical trials...
The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive Symptoms in 80 Patients With Unipolar or Bipolar Depression: a Phase II Exploratory add-on Double Blind Placebo Controlled 2 Week Trial
Conditions
Interventions
JNJ-39393406
Placebo
Locations
4
Moldova
Clinical Psychiatric Hospital
Codru, Moldova
S.C. Stefi-Dent Srl
Botoșani, Romania
Hospital of Psychiatry and Neurology
Brasov, Romania
Spit. Clinic de Urgenta Militar "Dr. Stefan Odobleja"
Craiova, Romania
Start Date
February 1, 2016
Primary Completion Date
May 1, 2017
Completion Date
July 1, 2017
Last Updated
May 22, 2020
NCT07360600
NCT06793397
NCT07478393
NCT04123314
NCT06906939
NCT05851898
Lead Sponsor
Tangent Data
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions